Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

Executive summary Despite substantial progress in reducing the global impact of many non-
communicable diseases, including heart disease and cancer, morbidity and mortality due to …

Background In patients with ST-segment elevation myocardial infarction (STEMI) with
multivessel coronary artery disease, the time at which complete revascularization of …

Background Data regarding clinical outcomes after intravascular imaging–guided
percutaneous coronary intervention (PCI) for complex coronary-artery lesions, as compared …

The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker
of insulin resistance (IR). Recently, a considerable number of studies have provided robust …

Background A strategy of administering a transfusion only when the hemoglobin level falls
below 7 or 8 g per deciliter has been widely adopted. However, patients with acute …

Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Although substantial progress has been made in the diagnosis and treatment of acute
coronary syndromes, cardiovascular disease remains the leading cause of death globally …

Aim This clinical practice guideline for the evaluation and diagnosis of chest pain provides
recommendations and algorithms for clinicians to assess and diagnose chest pain in adult …